In fact, IgA, HMOs, and the breast milk microbiome appear to play a role in protecting the mucosal barrier, protecting against pro-inflammatory and dysbiosis states and thus preventing the risk of developing NEC. The gene discussed is CD79A; the disease is necrotizing enterocolitis.